The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
[EN] HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS<br/>[FR] DÉRIVÉS D'HYDANTOÏNE UTILES EN TANT QU'INHIBITEURS DE KV3
申请人:AUTIFONY THERAPEUTICS LTD
公开号:WO2012076877A1
公开(公告)日:2012-06-14
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
作者:Jason G.M. Morton、Laura D. Kwon、John D. Freeman、Jon T. Njardarson
DOI:10.1016/j.tetlet.2009.01.134
日期:2009.4
Detailed in this Letter is an Adler–Becker oxidation strategy towards vinigrol. The effects of substitution were shown to greatly impact successes of both the oxidative dearomatization and Diels–Alder reactions.
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.